Announced Wed, 22 Jul · 18:17 IST
NSE seeks clarification on Q1 FY2027 financial results
Compliance
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹2339.30
prior close
₹2335.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9+0.7+1.8-0.2-0.2-4.8————————
Up moveDown movePending
AI summary
The NSE has asked Beta Drugs Limited to clarify certain points on its financial results for the quarter ended 30 June 2026, under Regulation 33 of SEBI Listing Regulations. The company has not yet responded, and its reply is awaited. No details of the specific queries or any financial numbers have been shared.
Likely market impact
Procedural exchange query, no business impact yet. Watch for the company's response which may explain unusual items in results.